Literature DB >> 19103224

Purification of DNA from the cell-associated herpesvirus Marek's disease virus for 454 pyrosequencing using micrococcal nuclease digestion and polyethylene glycol precipitation.

Jeremy D Volkening1, Stephen J Spatz.   

Abstract

Methods for the isolation of DNA from cell-associated herpesviruses have often yielded samples contaminated with host cellular DNA. Because 2nd and 3rd generation nucleotide sequencers do not rely on molecular cloning of viral DNA, there is a need to develop methods for isolating highly pure DNA from these viruses. The cell-associated alphaherpesvirus Marek's disease virus (MDV-1) was chosen as a test virus for the development of such methodologies. The genomes of six MDV-1 strains have previously been sequenced using both Sanger dideoxy sequencing and 454 Life Sciences pyrosequencing. These genomes largely represent cell culture adapted strains due to the difficulty in obtaining large quantities of DNA from true low passage isolates. There are clear advantages in analyzing MDV-1 virus taken directly from infected tissues or low passage isolates since serial passage attenuates the virus. Procedures using an ATP-dependent exonuclease and Phi29 DNA polymerase to degrade host DNA selectively and amplify MDV-1 DNA enzymatically from total DNA preps were attempted without much success. Ultimately, however, a protocol was developed for purification of low passage MDV-1 DNA from infected avian fibroblasts. The method builds upon and extends available protocols based on hypotonic lysis to release virus particles followed by micrococcal nuclease treatment to degrade cellular DNA. Intact high-molecular weight viral DNA is purified away from an excess of degraded cellular DNA using polyethylene glycol precipitation. 454-based pyrosequencing of viral DNA purified in this manner has generated data containing as little as 2.3% host sequence. On average, DNA preparations were 70% (+/-20%) pure yielding a genome coverage range of 25-74-fold.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19103224     DOI: 10.1016/j.jviromet.2008.11.017

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  10 in total

1.  Comparative genomic sequence analysis of the Marek's disease vaccine strain SB-1.

Authors:  Stephen J Spatz; Karel A Schat
Journal:  Virus Genes       Date:  2011-02-20       Impact factor: 2.332

2.  Comparative full genome analysis of four infectious laryngotracheitis virus (Gallid herpesvirus-1) virulent isolates from the United States.

Authors:  S J Spatz; J D Volkening; C L Keeler; G F Kutish; S M Riblet; C M Boettger; K F Clark; L Zsak; C L Afonso; E S Mundt; D L Rock; M Garcia
Journal:  Virus Genes       Date:  2011-12-16       Impact factor: 2.332

3.  Large-scale sequencing and the natural history of model human RNA viruses.

Authors:  Vivien G Dugan; Kazima Saira; Elodie Ghedin
Journal:  Future Virol       Date:  2012-06-01       Impact factor: 1.831

4.  Expression of chicken parvovirus VP2 in chicken embryo fibroblasts requires codon optimization for production of naked DNA and vectored meleagrid herpesvirus type 1 vaccines.

Authors:  Stephen J Spatz; Jeremy D Volkening; Robert Mullis; Fenglan Li; John Mercado; Laszlo Zsak
Journal:  Virus Genes       Date:  2013-07-17       Impact factor: 2.332

5.  Dynamic equilibrium of Marek's disease genomes during in vitro serial passage.

Authors:  Stephen J Spatz; Jeremy D Volkening; Isabel M Gimeno; Mohammad Heidari; Richard L Witter
Journal:  Virus Genes       Date:  2012-08-26       Impact factor: 2.332

6.  Marek's Disease Virus Requires Both Copies of the Inverted Repeat Regions for Efficient In Vivo Replication and Pathogenesis.

Authors:  Tereza Vychodil; Andelé M Conradie; Jakob Trimpert; Amr Aswad; Luca D Bertzbach; Benedikt B Kaufer
Journal:  J Virol       Date:  2021-01-13       Impact factor: 5.103

7.  Characterizing the molecular basis of attenuation of Marek's disease virus via in vitro serial passage identifies de novo mutations in the helicase-primase subunit gene UL5 and other candidates associated with reduced virulence.

Authors:  Evin Hildebrandt; John R Dunn; Sudeep Perumbakkam; Masahiro Niikura; Hans H Cheng
Journal:  J Virol       Date:  2014-03-19       Impact factor: 5.103

8.  Full genome sequences of zebra-borne equine herpesvirus type 1 isolated from zebra, onager and Thomson's gazelle.

Authors:  Xiaoqin Guo; Satoko Izume; Ayaka Okada; Kenji Ohya; Takashi Kimura; Hideto Fukushi
Journal:  J Vet Med Sci       Date:  2014-06-11       Impact factor: 1.267

9.  Recombinant Marek's disease virus type 1 provides full protection against very virulent Marek's and infectious bursal disease viruses in chickens.

Authors:  Kai Li; Yongzhen Liu; Changjun Liu; Li Gao; Yanping Zhang; Hongyu Cui; Yulong Gao; Xiaole Qi; Li Zhong; Xiaomei Wang
Journal:  Sci Rep       Date:  2016-12-16       Impact factor: 4.379

10.  The full genome sequences of 8 equine herpesvirus type 4 isolates from horses in Japan.

Authors:  Satoko Izume; Rikio Kirisawa; Kenji Ohya; Aiko Ohnuma; Takashi Kimura; Tsutomu Omatsu; Yukie Katayama; Tetsuya Mizutani; Hideto Fukushi
Journal:  J Vet Med Sci       Date:  2016-11-14       Impact factor: 1.267

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.